Ecolab provides water, hygiene and infection prevention solutions and services to customers in hospitality, food service, health care, manufacturing and energy. It sells cleaning and sanitising chemicals, dispensing equipment and monitoring technology, and its representatives visit customer sites to manage programmes. Because customers repeatedly purchase consumables and services, a large part of its revenue is recurring, and costs for raw materials affect its margins.
Trailing twelve-month revenue stands at $16.8 billion, while revenue grew by 4.3% a year over the past three years. Return on invested capital is 13%, alongside an operating margin of 16.9%. Net debt is 2.8 times EBITDA. The company pays a dividend, and the yield is 1.0%. On the X-Ray Score, it is rated 50 out of 100. These figures describe past results and the present financial position only.
Written with AI from public information and the filing figures on this page, then checked automatically for unsupported numbers. It can contain mistakes: read the company's own filings below before relying on it.
52-wk range $241.85 – $306.79Volume 3,400,304Daily, split-adjusted
Vitals
Market cap$81.5B
52-week range$241.85 – $306.79
Volume (last day)3,400,304
P/E (TTM)38.8
EBIT / EV yield3.2%
Free-cash-flow yield2.3%
Dividend yield1.0%
Revenue (TTM)$16.8B
Net income (TTM)$2.1B
Operating margin16.9%
Return on capital12.8%
Debt incl. leases$13.2B
Cash & securities$5.1B
Debt = borrowings plus lease liabilities. Cash & securities = cash, equivalents and short-term marketable securities (long-term securities are not counted, so net cash can be understated for companies like Apple). Net debt = debt minus cash & securities. Source: latest SEC 10-Q/10-K. EBIT / EV yield = operating profit divided by market cap plus net debt.
Fair value estimate
$146model spread $137 – $156
Overvalued−49.6% to fair value
Equal blend of three models: peer multiples, a fundamentals-adjusted multiple (growth, ROIC and margin) and a 10-year DCF scaled to the market's average. Earnings-power value (no growth) is a floor and not part of the blend. Model uncertainty is Medium, so the safety margin is 30%.
Multiples use through-the-cycle earnings (0.83x of the last twelve months)
A model estimate, not a price target or recommendation. Inputs: risk-free 5.09%, equity risk premium 4.23% (Damodaran). How it works.
What this means
Average business, priced high
Our models put fair value below today's price, so a lot of good news may already be in the price. A high score does not guarantee a good outcome; it shifts the odds a little. Use the checklist as a prompt for your own research.
Before you invest · decision checklist
Ticked boxes are filled in from our data; the rest are yours to answer.
The five-lens scan
Every score explained in one sentence, ranked against Materials peers. Open a lens to see the numbers behind it.
ValuationWeak
16/100
Expensive against its sector on earnings and cash flow.
See the numbers →
EBIT / EV yield3.2%
Free-cash-flow yield2.3%
Fair value vs price0.5×
GrowthStrong
71/100
Growing faster than most of its sector.
See the numbers →
Revenue growth (3y)4.3%
EPS growth (3y)24.1%
Growth consistency90%
ProfitabilityFair
64/100
Returns on capital are typical for its sector.
See the numbers →
Return on invested capital12.8%
Operating margin16.9%
Gross profitability24.8%
Financial healthFair
52/100
Balance sheet is in typical shape for its sector.
See the numbers →
Piotroski F-Score6 / 9
Net debt / EBITDA2.8×
Interest cover8.6×
DividendsFair
56/100
Dividend is typical for its sector.
See the numbers →
Dividend yield1.0%
Dividends vs free cash flow44%
Dividend growth7.7%
Quarterly results: last 6 quarters
-1.5%Mar '25
+1.0%Jun '25
+4.2%Sep '25
+4.8%Dec '25
+10.0%Mar '26
+9.7%Jun '26
Revenue against the same quarter a year earlier. Latest quarter revenue $4.4B, diluted EPS $1.90.
Other Specialty Chemicals companies by X-Ray Score.
Fundamentals checklist
● 7 Good · ● 5 Average · ● 4 Bad
Cash quality
Earnings backed by cashBad
Free-cash-flow yieldBad
Risk models
Altman Z''Good
Piotroski F-ScoreAverage
Growth
EPS growth (3y)Good
Free-cash-flow growth (3y)Average
Revenue growth (3y)Good
Growth consistencyGood
Balance sheet
Current ratioAverage
Net debt / EBITDAAverage
Interest coverAverage
Valuation
Fair value vs priceBad
EBIT / EV yieldBad
Profitability
Return on invested capitalGood
Operating marginGood
Gross profitabilityGood
Each check is graded against the company's sector, not a fixed number. Checklist score 53/100.
Financials
FY21
FY22
FY23
FY24
FY25
Revenue
$12.7B
$14.2B
$15.3B
$15.7B
$16.1B
Operating income
$1.6B
$1.6B
$2.0B
$2.8B
$2.7B
Net income
$1.1B
$1.1B
$1.4B
$2.1B
$2.1B
Operating cash flow
$2.1B
$1.8B
$2.4B
$2.8B
$3.0B
Operating margin
12.6%
11.0%
13.0%
17.8%
17.0%
Free cash flow
$1.4B
$1.1B
$1.6B
$1.8B
$1.9B
Diluted EPS
$3.91
$3.81
$4.79
$7.37
$7.28
Fiscal years, from SEC filings.
Technical summary
Daily
Strongly bullish
12 bullish · 3 neutral · 1 bearish
Weekly
Strongly bullish
11 bullish · 1 neutral · 0 bearish
Monthly
Strongly bullish
7 bullish · 1 neutral · 0 bearish
Moving averages (daily)
SMA 10
283.7
Bullish
EMA 10
284.5
Bullish
SMA 20
279.6
Bullish
EMA 20
281.5
Bullish
SMA 50
279.3
Bullish
EMA 50
278.6
Bullish
SMA 100
274.7
Bullish
EMA 100
275.8
Bullish
SMA 200
273.6
Bullish
EMA 200
272.4
Bullish
Oscillators (daily)
RSI (14)
63.63
Neutral
MACD (12, 26)
3.00
Bullish
Momentum (12)
5.21
Bullish
Stochastic %K (14)
75.22
Neutral
Williams %R (14)
-24.78
Neutral
CCI (20)
155.9
Bearish
Pivot points (classic, last session)
S3
276.9
S2
281.4
S1
285.2
Pivot
289.7
R1
293.5
R2
298.0
R3
301.7
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Dividends
Paid, last 12 months
2.92 USD
Yield on today's price
1.01%
Frequency
Quarterly
Next ex-dividend date
Not announced
Ex-dividend date
Amount per share
15 Sep 2026
0.7300
16 Jun 2026
0.7300
17 Mar 2026
0.7300
16 Dec 2025
0.7300
16 Sep 2025
0.6500
17 Jun 2025
0.6500
18 Mar 2025
0.6500
17 Dec 2024
0.6500
17 Sep 2024
0.5700
18 Jun 2024
0.5700
18 Mar 2024
0.5700
18 Dec 2023
0.5700
Ex-dividend dates and amounts from EODHD. Shown as declared, before tax.